Skip to content

Clinical trials

Stroke trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Not applicable Country / region: Canada Clear all

217 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20063
20071
20083
20094
20105
20119
20126
20137
20149
201515
201613
201714
201814
201915
202017
202110
202216
20238
202411
202515
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119
Unknown status34
Recruiting34
Not yet recruiting11
Terminated10
Active, not recruiting7
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia24
University Health Network, Toronto16
McGill University15
Sunnybrook Health Sciences Centre12
University of Calgary12
McMaster University11
University of Alberta10
Nova Scotia Health Authority9
Université de Sherbrooke8
Toronto Rehabilitation Institute6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke217
Cardiovascular Diseases16
Ischemic Stroke15
Atrial Fibrillation13
Brain Injuries10
Brain Infarction8
Brain Injuries, Traumatic8
Cerebral Infarction8
Cerebrovascular Disorders8
Heart Failure8

Trials

Showing 1 to 25 of 217. Each trial links to its page on Pharma Observatory.

117 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.